Interpace Biosciences, Inc. IDXG

Full chart Compare
Set alert

Price alert · IDXG

All alert types
5.35 USD -0.37 (-6.47%)

At closeOct 30, 2026, 4:00 PM EDT

5.35 Day range 5.35
0.806 52-week range 7.80
YTD
+334.96%
1 year
+424.51%

Analyst view

Consensus: buy

Buy
Price target (mean) 8.43 +57.6% upside
Target (low)
6.00
Target (mean)
8.43
Target (high)
12.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 4
  • 2 months ago 4
  • 3 months ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

IDXG analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.15-1.35 – -0.77-2.95+61.0%8.85M+117.2%3
Next quarter-1.05-1.18 – -0.93-2.32+54.7%10.28M0.0%2
Current year-6.02-6.62 – -5.71-7.25+17.0%31.43M+30.5%3
Next year-1.94-3.61 – -0.60-6.02+67.8%45.55M+44.9%3

Upgrades and downgrades

The latest rating changes

IDXG analyst upgrades and downgrades
DateFirmActionFromTo
Jan 24, 2021HC Wainwright & Co.Maintained—Buy
Oct 21, 2020HC Wainwright & Co.Maintained—Buy
Jun 25, 2020HC Wainwright & Co.Maintained—Buy
Apr 22, 2020H.C. WainwrightMaintained—Buy
Apr 14, 2020Janney CapitalInitiated—Buy
Jan 15, 2020OppenheimerMaintained—Outperform